These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34334251)

  • 1. Peptide-drug conjugate-based novel molecular drug delivery system in cancer.
    Zhu YS; Tang K; Lv J
    Trends Pharmacol Sci; 2021 Oct; 42(10):857-869. PubMed ID: 34334251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery and release systems for targeted tumor therapy.
    Böhme D; Beck-Sickinger AG
    J Pept Sci; 2015 Mar; 21(3):186-200. PubMed ID: 25703117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.
    Alas M; Saghaeidehkordi A; Kaur K
    J Med Chem; 2021 Jan; 64(1):216-232. PubMed ID: 33382619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug conjugate-based anticancer therapy - Current status and perspectives.
    Yang Y; Wang S; Ma P; Jiang Y; Cheng K; Yu Y; Jiang N; Miao H; Tang Q; Liu F; Zha Y; Li N
    Cancer Lett; 2023 Jan; 552():215969. PubMed ID: 36279982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
    Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide Drug Conjugates and Their Role in Cancer Therapy.
    Heh E; Allen J; Ramirez F; Lovasz D; Fernandez L; Hogg T; Riva H; Holland N; Chacon J
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart linkers in polymer-drug conjugates for tumor-targeted delivery.
    Chang M; Zhang F; Wei T; Zuo T; Guan Y; Lin G; Shao W
    J Drug Target; 2016; 24(6):475-91. PubMed ID: 26560242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency.
    Wang MD; Hou DY; Lv GT; Li RX; Hu XJ; Wang ZJ; Zhang NY; Yi L; Xu WH; Wang H
    Biomaterials; 2021 Nov; 278():121139. PubMed ID: 34624753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide-Mediated Tumor-Targeted Drug Delivery via a Cleavable Doxorubicin-Peptide Conjugate.
    Lelle M; Kaloyanova S; Freidel C; Theodoropoulou M; Musheev M; Niehrs C; Stalla G; Peneva K
    Mol Pharm; 2015 Dec; 12(12):4290-300. PubMed ID: 26524088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-Based Drug Delivery Systems.
    Berillo D; Yeskendir A; Zharkinbekov Z; Raziyeva K; Saparov A
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer.
    Soudy R; Etayash H; Bahadorani K; Lavasanifar A; Kaur K
    Mol Pharm; 2017 Mar; 14(3):593-604. PubMed ID: 28157321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis.
    Tashima T
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3015-3024. PubMed ID: 30031619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery.
    Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y
    Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models.
    Chau Y; Padera RF; Dang NM; Langer R
    Int J Cancer; 2006 Mar; 118(6):1519-26. PubMed ID: 16187287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.
    Shi NQ; Qi XR
    ACS Appl Mater Interfaces; 2017 Mar; 9(12):10519-10529. PubMed ID: 28290666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geometry encoded functional programming of tumor homing peptides for targeted drug delivery.
    Goyal R; Jerath G; Akhil R; Chandrasekharan A; Puppala ER; Ponneganti S; Sarma A; Naidu VGM; Santhoshkumar TR; Ramakrishnan V
    J Control Release; 2021 May; 333():16-27. PubMed ID: 33722612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.